Gennex Laboratories Share Price

Gennex Laboratories Limited, formerly known as Prudential Pharmaceuticals Limited was incorporated on June 25, 1985. The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007.The Company is in the business of Manufacturing of Bulk Drugs, Intermediates and Biotech Products. The Company has over the years added more capacity and infrastructure by way of an additional production block and equipment to the plant to handle more products and tonnages. The Company is having a professionally managed team at every stage of its operations.Apart from these, Gennex is among the leading Vertically Integrated pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal. The company thrives on the strength of its exports to various countries viz. Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and Others. The Companys factory is situated at Andhra Pradesh, India. The company has a professionally managed team at every stage of its operations.During the year 20052006, the company implemented GMP (Good Manufacturing Practices). In 200607, it installed Separate Air Handling System in final drug isolation area and also in drying and packing area. Also, it implemented the CGMP in manufacturing area as per ICH WHO Guidelines. In 20072008, it diversified into the business of Biotech product. The Company acquired 51% shareholding in Deccan Remedies Limited and thus became the subsidiary of the Company in 2023.

For the full year FY2025–2026, revenue reached ₹148.33 crore and profit touched at ₹18.12 crore.